Isracann Biosciences Inc. (ISCNF) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Drug Manufacturers - Specialty & Generic industria. La empresa tiene su sede en Vancouver, BC, Canada. El CEO actual es Ajay Singh Kaila.
ISCNF tiene fecha de IPO 2017-12-15, cotiza en el Other OTC, una capitalización de mercado de $1.98K.
Isracann Biosciences Inc., together with its subsidiaries, cultivates and distributes medical cannabis in Israel. The company also develops cultivation facilities. It exports its products to Germany. The company was formerly known as Atlas Blockchain Group Inc. and changed its name to Isracann Biosciences Inc. in October 2019. Isracann Biosciences Inc. was founded in 2010 and is headquartered in Vancouver, Canada.
